Skip to content

    Recently Viewed

      Listening...

      Home /
      The Road to a Vaccine

      The Road to a Vaccine: Everything you need to know about COVID-19 testing and contact tracing

      In Season 2 of The Road to a Vaccine, host Lisa Ling interviews scientists, global health leaders and other experts on the COVID-19 front lines to reveal the latest medical advances and collaborations to create a coronavirus vaccine—and hopefully a return to a world without the pandemic.


      In Episode 6 of The Road to a Vaccine, Lisa Ling speaks to experts—including Ann Lee, co-founder, with actor Sean Penn, of the nonprofit CORE—to get the latest updates on testing efforts and contact tracing across America.
      RTAV: Season 2, Episode 6
      Ann Lee talking about COVID-19 and contact tracing

      Lisa Ling

      Ling is the Executive Producer and host of This Is Life on CNN. She has also been a field correspondent for The Oprah Winfrey Show and a contributor to ABC News’ Nightline.
      Side profile of Ann Lee

      Ann Lee

      Lee is the Chief Executive Officer of CORE (Community Organized Relief Effort), formerly J/P HRO, Sean Penn’s disaster relief charity, where she has overseen the successful transition from a Haiti-based recovery organization to an international response and resilience-building NGO. Previously, she worked at the UN’s Organization for Coordination and Humanitarian Affairs (OCHA). Lee is the author of Livelihoods in Emergencies: A Double-Edged Sword.
      RTAV Fiona Lowenstein

      Fiona Lowenstein

      Lowenstein is a writer, speaker, TV producer and media consultant based in New York City. She is the founder of Body Politic, a queer feminist wellness collective, events series and media start-up, and the co-founder of the Body Politic COVID-19 Support Group, which provides emotional support and resources to thousands of patients all over the world. Her writing has been published in The New York Times, Vox and The Columbia Journalism Review, among others.
      inset-dr-mammen-jnj-vaccine-q-a.jpg

      Mathai Mammen, M.D., Ph.D.

      Dr. Mammen is Global Head of Janssen Research & Development, Johnson & Johnson. Previously, he was Senior Vice President at Merck Research Laboratories. He received his M.D. from Harvard Medical School/Massachusetts Institute of Technology (HST program) and his Ph.D. in Chemistry from Harvard University.
      RTAV Todd Wolynn, M.D.

      Todd Wolynn, M.D.

      Dr. Wolynn is co-founder and Advisory Board President of Shots Heard Round the World, a non-profit organization dedicated to defending and empowering vaccine advocates.

      Johnson & Johnson signs a historic pledge to uphold the integrity of the scientific process in developing an investigational COVID-19 vaccine

      In signing the pledge, we are joining eight other biopharmaceutical companies working on vaccine research and development in making the safety and well-being of vaccinated individuals our top priority.
      You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.